GlassScriptPhysician profile
David J Matthews
NPI 1043447394
$12,304.36
in general payments reported to CMS, 2019-2025
27 companies · $461 in 2025
The $461 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.68 · 2020: $207 · 2021: $247 · 2022: $11K · 2023: $265 · 2024: $171 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,516.00 | 2022 | |
| Abbvie INC. | $290.80 | 2020-2023 | |
| Exeltis, USA INC. | $218.05 | 2021-2025 | Slynd |
| Organon LLC | $155.10 | 2022-2025 | Nexplanon, Jada System |
| Hologic Sales and Service, LLC | $153.43 | 2020-2025 | Myosure Tissue Removal Device, Aptima |
| Channel Medsystems, INC. | $120.74 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.40 | 2019-2023 | |
| Allergan, INC. | $96.55 | 2019-2020 | |
| Astellas Pharma US INC | $92.31 | 2024-2025 | Veozah |
| Therapeuticsmd, INC. | $68.83 | 2019-2022 | |
| Biogen, INC. | $66.22 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $66.01 | 2025 | |
| Evofem Biosciences, INC. | $62.41 | 2022 | |
| Medtronic, INC. | $48.50 | 2022 | |
| Valencia Technologies Corporation | $37.90 | 2025 | Ecoin Device Kit |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $34.94 | 2022-2023 | Gardasil 9 |
| Nestle Healthcare Nutrition INC. | $21.63 | 2021 | |
| Conmed Corporation | $20.23 | 2025 | Airseal |
| Agile Therapeutics, INC. | $18.67 | 2021 | |
| Pfizer INC. | $17.46 | 2025 | |
| Dexcom, INC. | $17.20 | 2025 | Dexcom G6 Transmitter |
| Ethicon US, LLC | $16.76 | 2025 | Harmonic, Enseal X1 |
| Sumitomo Pharma America, INC. | $15.36 | 2025 | Myfembree |
| Coopersurgical, INC. | $13.94 | 2024 | Summit Doppler |
| Lupin INC. | $11.59 | 2020 | |
| Zyla Life Sciences, INC. | $11.24 | 2020 | |
| Meditrina | $10.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.